WEKO3
アイテム
Validation of regional myocardial blood flow quantification using three-dimensional PET with rubidium-82
https://repo.qst.go.jp/records/80083
https://repo.qst.go.jp/records/80083151bc82d-5db8-4414-a9f0-23b74d3f7cab
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2020-06-16 | |||||
タイトル | ||||||
タイトル | Validation of regional myocardial blood flow quantification using three-dimensional PET with rubidium-82 | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Osamu, Managbe
× Osamu, Managbe× Ran, Klein× Chietsugu, Katoh× Keiichi, Magota× Robert A., deKemp× Masanao, Naya× Nagara, Tamaki× Yoshinaga, Keiichiro× Yoshinaga, Keiichiro |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Introduction: Three-dimensional (3D) data acquisition is now standard on PET/computed tomography scanners. The aim of this study was to evaluate the repeatability of myocardial blood flow (MBF) estimation with rubidium-82 (Rb) 3D PET and to validate regional MBF measurements by comparison with two-dimensional (2D) PET. Patients and methods: Fifteen healthy individuals (31.6 ± 11.4 years old) were enrolled for the evaluation of the short-term repeatability of rest 3D MBF quantification. Another 19 healthy individuals (35.3 ± 12.6 years old) underwent rest and pharmacological stress PET using 2D and 3D data acquisition within a 1-month interval. The injected dose was 1500 MBq for 2D and 555 MBq for 3D PET acquisition. Results: MBF at rest showed good repeatability [whole left ventricular MBF; 0.54 ± 0.13 vs. 0.52 ± 0.13 mL/min/g, P = 0.98]. Rest MBF, stress MBF, and myocardial flow reserve (MFR) were not significantly different between 3D and 2D data acquisition. 3D MBF correlated well with 2D MBF over a wide flow range for both whole left ventricular (r = 0.97, P < 0.0001) and regional values (r = 0.61, P < 0.0001). Conclusion: MBF measured with 3D PET showed very good test-retest repeatability. Whole left ventricular and regional MBF measurements obtained using lower Rb-dose 3D PET were highly correlated over a wide range with those from 2D PET. Therefore, MBF with 3D PET can be applied using a lower Rb dosage in clinical settings with reduced radiation exposure. |
|||||
書誌情報 |
Nuclear Medicine Communications 巻 41, 号 8, p. 768-775, 発行日 2020-05 |
|||||
出版者 | ||||||
出版者 | Wolters Kluwer Health, Inc. | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0143-3636 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 32459715 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1097/MNM.0000000000001218 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://journals.lww.com/nuclearmedicinecomm/Abstract/2020/08000/Validation_of_regional_myocardial_blood_flow.9.aspx |